Diagnostic Evaluations of Autism Spectrum Disorder during the COVID-19 Pandemic. Academic Article uri icon

Overview

abstract

  • A global pandemic has significantly impacted the ability to conduct diagnostic evaluations for autism spectrum disorder (ASD). In the wake of the coronavirus, autism centers and providers quickly needed to implement innovative diagnostic processes to adapt in order to continue serve patient needs while minimizing the spread of the virus. The International Collaborative for Diagnostic Evaluation of Autism (IDEA) is a grassroots organization that came together to discuss standards of care during the pandemic and to provide a forum wherein providers communicated decisions. This white paper is intended to provide examples of how different centers adjusted their standard approaches to conduct diagnostic evaluations for ASD during the pandemic and to provide insight to other centers as they go through similar challenges.

publication date

  • March 17, 2021

Research

keywords

  • Autism Spectrum Disorder
  • Autistic Disorder
  • COVID-19

Identity

PubMed Central ID

  • PMC7970766

Scopus Document Identifier

  • 85102929833

Digital Object Identifier (DOI)

  • 10.1007/s10803-004-2544-y

PubMed ID

  • 33730320

Additional Document Info

volume

  • 52

issue

  • 2